PH23384A - Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof - Google Patents

Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof

Info

Publication number
PH23384A
PH23384A PH33379A PH33379A PH23384A PH 23384 A PH23384 A PH 23384A PH 33379 A PH33379 A PH 33379A PH 33379 A PH33379 A PH 33379A PH 23384 A PH23384 A PH 23384A
Authority
PH
Philippines
Prior art keywords
pharmaceutical
containing compositions
method use
ergot alkaloid
alkaloid containing
Prior art date
Application number
PH33379A
Other languages
English (en)
Inventor
Othmar Zuger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH23384A publication Critical patent/PH23384A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH33379A 1985-02-05 1986-02-04 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof PH23384A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (1)

Publication Number Publication Date
PH23384A true PH23384A (en) 1989-07-26

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33379A PH23384A (en) 1985-02-05 1986-02-04 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof

Country Status (24)

Country Link
JP (1) JPS61183225A (ko)
KR (1) KR920010388B1 (ko)
AU (1) AU597570B2 (ko)
BE (1) BE904152A (ko)
CA (1) CA1263087A (ko)
CH (1) CH667592A5 (ko)
CY (1) CY1604A (ko)
DE (1) DE3602577A1 (ko)
DK (1) DK167138B1 (ko)
ES (1) ES8800040A1 (ko)
FR (1) FR2576787B1 (ko)
GB (1) GB2170407B (ko)
GR (1) GR860310B (ko)
HK (1) HK57191A (ko)
HU (1) HU195729B (ko)
IE (1) IE59293B1 (ko)
IT (1) IT1191255B (ko)
LU (1) LU86289A1 (ko)
NL (1) NL8600161A (ko)
NZ (1) NZ215020A (ko)
PH (1) PH23384A (ko)
PT (1) PT81954B (ko)
SE (1) SE8600496L (ko)
SG (1) SG56191G (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
SI8710406B (sl) * 1987-03-11 1998-08-31 Lek Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
ES2236017T3 (es) * 1999-12-03 2005-07-16 Polichem S.A. Procedimientos para la prepaaraciones farmaceuticas de liberacion sostenida de alcaloides del ergot que tienen biodfisponibilidad mejorada y composiciones de los mismos.
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
CA2408541C (en) * 2000-05-12 2009-07-28 Meracol Corporation Limited Treating eczema and/or psoriasis
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2001085162A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating irritable bowel syndrome or disease
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
IT8647620A0 (it) 1986-02-05
ES8800040A1 (es) 1987-10-16
CH667592A5 (de) 1988-10-31
NZ215020A (en) 1989-07-27
GB8602602D0 (en) 1986-03-12
CA1263087A (en) 1989-11-21
IE59293B1 (en) 1994-02-09
FR2576787B1 (fr) 1990-01-12
DK167138B1 (da) 1993-09-06
KR920010388B1 (ko) 1992-11-27
DE3602577A1 (de) 1986-08-28
IE860291L (en) 1986-08-05
HUT41984A (en) 1987-06-29
LU86289A1 (fr) 1986-09-02
AU597570B2 (en) 1990-06-07
GR860310B (en) 1986-05-27
PT81954A (en) 1986-03-01
HK57191A (en) 1991-08-02
AU5294286A (en) 1986-08-14
BE904152A (fr) 1986-08-04
DK52086D0 (da) 1986-02-03
CY1604A (en) 1992-04-03
GB2170407B (en) 1988-10-26
NL8600161A (nl) 1986-09-01
SE8600496L (sv) 1986-08-06
PT81954B (pt) 1988-07-01
IT1191255B (it) 1988-02-24
HU195729B (en) 1988-07-28
KR860006265A (ko) 1986-09-09
DK52086A (da) 1986-08-06
ES551635A0 (es) 1987-10-16
GB2170407A (en) 1986-08-06
FR2576787A1 (fr) 1986-08-08
SG56191G (en) 1991-08-23
SE8600496D0 (sv) 1986-02-04
JPS61183225A (ja) 1986-08-15

Similar Documents

Publication Publication Date Title
NZ217931A (en) Pyridone derivatives and pharmaceutical compositions
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
PH23495A (en) Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof
PH24749A (en) Piperidine compounds, pharmaceutical composition and method of use thereof
IL78872A0 (en) Morphinan derivatives and pharmaceutical compositions containing them
PH24326A (en) Substituted 3,4-dihydro-2h-benzopyrans,pharmaceutical compositions containing same and method of use thereof
NZ218428A (en) Heterocyclically-substituted quinoline derivatives and pharmaceutical compositions
NZ215871A (en) Fluorinated phenylalkyl-triazole derivatives and pharmaceutical compositions
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
DE3664774D1 (en) Novel 1,8-naphthyridine derivatives and processes for preparation thereof
IL86711A0 (en) 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
PH23384A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
IL80540A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
PH24135A (en) Quinoline derivatives and pharmaceutical composition containing said compounds
IL78642A0 (en) Dihydropyridines and pharmaceutical compositions containing them
IL74071A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
GR861027B (en) (-)-1b-ethyl-1a-hydroxymethyl-1,2,3,4,6,7,12,12ba-octahydroindolo(2,3-a) quinolizine process for its preparation and pharmaceutical compositions containing same
NZ216555A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
NZ214815A (en) 12-aminopyridazinopyrroloisoquinoline derivatives and pharmaceutical compositions
ZA861074B (en) Novel 1,8-naphthyridine derivatives and processes for preparation thereof
IL80733A0 (en) 2,2'-bi-1h-imidazoles and pharmaceutical compositions containing same
NZ215083A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
GB2173189B (en) Ergoline derivatives and salts thereof and pharmaceutical compositions thereof